About Spencer R. Scott

This author has not yet filled in any details.
So far Spencer R. Scott has created 11 blog entries.

SynBioBeta SF 2015 In Summary: The Race to Bring Valuable Products to Market

Another amazing year at the SynBioBeta Conference in San Francisco. I believe the underlying pulse of the SynBioBeta conference was summarily precipitated by Randal J. Kirk’s insightful declaration that As synthetic biologists, we won’t win the public’s favor through an [...]

By | November 7th, 2015|Synthetic Biology News|

At SynBioBeta SF 2015, Companies Announce Exciting Partnerships to Accelerate Design-to-Creation Pipeline

This year at the SynBioBeta San Francisco Conference there was a lot of exciting news and innovations from the numerous companies in attendance. However, some of the most special moments were the announcement of partnerships designed to accelerate the rate [...]

By | November 7th, 2015|Synthetic Biology News|

Ginkgo Bioworks and Twist Bioscience Just Made a 100 Million Base Pair Deal

Today at the SynBioBeta Conference in San Francisco, Ginkgo Bioworks and Twist Bioscience will announce an exciting partnership that promises Ginkgo will order a minimum of 100 million base pairs of synthesized DNA from Twist in the next year. This [...]

Thermo Fisher Scientific Makes Genetic Modification Look Easy

This year Thermo Fisher Scientific has made impressively swift adaptations to the rapidly changing landscape of genetic engineering. By doing so, they have positioned themselves to cater to scientists’ needs at the forefront of research by introducing new products and [...]

Zymergen Raises $44 Million Series A to Automate Microbial Engineering

Over the last two years, Zymergen has been working hard to develop better methods to optimize microbes for industrial fermentation. Their integrated approach, which combines robotic automation, large datasets, machine learning, and novel software algorithms to engineer industrial microbes dramatically [...]

Synthetic Genomics and Gen9 Team Up to Advance DNA Synthesis

Synthetic Genomics have announced that it will license several patents covering a wide range of their sequencing technology to Gen9 Inc., the Cambridge-based gene synthesis company. The agreement, of which financial details were not disclosed, provides Gen9 with non-exclusive worldwide [...]